FDA Inspection 614275 — Keystone Pharmaceuticals Inc.
The FDA completed an inspection of Keystone Pharmaceuticals Inc. on October 5, 2009 in Laguna Hills, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 5, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Laguna Hills, CA (United States)